Making the impossible possible
Discover how we're using the power of innovation to change people’s lives for the better
LEARN MOREPharmaceutical industry response to the war in Ukraine
Our Member Companies and Associations are offering humanitarian support both in Ukraine and for the emerging refugee crisis in neighbouring EU Member States.
LEARN MORE
Help us make rare disease even rarer
Only 8 OMP medicines existed in 2000, before the EU Regulation came in to force, compared to 184 today.
LEARN MORE
Relationships and Code
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
LEARN MORE
Latest Updates
VIEW ALL-
Blog articles 03.10.22
Pushing the boundaries of science for the benefit of patients
EFPIA's 2022 Pipeline Report
Read Article -
Blog articles 30.09.22
A fact-based analysis of the TRIPS Waiver extension
A COVID-19 TRIPS waiver extension can harm patients
Read Article -
Statements & press releases 28.09.22
‘TEE’ system will revitalise antibiotic research and save money for Europe, new evidence shows
New and novel antibiotics are urgently needed to help tackle the global health threat of antimicrobial resistance (AMR), as infections become more resistant...
Read Article -
External Events 15.10.22
35th Annual Congress of the European Association of Nuclear Medicine
The EANM Annual Congress is the most valuable Nuclear Medicine Meeting worldwide.
View Event -
External Events 10.11.22
Investor Perspective: The Strategic Venturing Spectrum
Webinar by Johnson & Johnson Innovation
View Event -
Partner Event 15.11.22
EU HEALTH SUMMIT 2022: TOWARDS AN EU HEALTH UNION
An EU Health Coalition event
View Event
Featured Articles
Featured article
Pharmaceutical industry response to the war in Ukraine
Supporting people affected by the war
Read more